Prognostic value of baseline metabolic tumor volume (MTV) for forecasting chemotherapy outcome in early-stage unfavorable Hodgkin lymphoma: Data from the phase III HD17 trial.

European journal of haematology(2023)

引用 0|浏览9
暂无评分
摘要
ClinicalTrials.gov NCT01356680.
更多
查看译文
关键词
FDG PET, Hodgkin lymphoma, metabolic tumor volume, response prediction
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要